血浆脂质与主动脉瓣狭窄风险的孟德尔随机化研究
结果显示,低密度脂蛋白胆固醇每升高0.98 mmol/L,主动脉瓣狭窄风险增加(OR 1.52,95%CI 1.22-1.90),而高密度脂蛋白胆固醇和甘油三酯无显著因果关联,且脂质参数与主动脉瓣或二尖瓣反流无因果关联。结论提示终身暴露于高LDL胆固醇增加症状性主动脉瓣狭窄风险,降LDL治疗可能有效预防。
要点
- LDL胆固醇每升高0.98 mmol/L,主动脉瓣狭窄风险增加52%。
- HDL胆固醇和甘油三酯与主动脉瓣狭窄无显著因果关联。
- 脂质参数与主动脉瓣或二尖瓣反流无因果关联。
核心结论
- 终身暴露于高LDL胆固醇增加症状性主动脉瓣狭窄风险,提示降LDL治疗可能有效预防。
主要发现
- LDL胆固醇每升高0.98 mmol/L,主动脉瓣狭窄的OR为1.52(95%CI 1.22-1.90)。
- HDL胆固醇每升高0.41 mmol/L,OR为1.03(95%CI 0.80-1.31)。
- 甘油三酯每升高1 mmol/L,OR为1.38(95%CI 0.92-2.07)。
- 任何脂质参数与主动脉瓣或二尖瓣反流均无因果关联证据。
临床怎么用
- 对于高LDL胆固醇患者,应考虑降LDL治疗以预防主动脉瓣狭窄。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Aortic valve stenosis is commonly considered a degenerative disorder with no recommended preventive intervention, with only valve replacement surgery or catheter intervention as treatment options. We sought to assess the causal association between exposure to lipid levels and risk of aortic stenosis. METHODS AND RESULTS: Causality of association was assessed using two-sample Mendelian randomization framework through different statistical methods. We retrieved summary estimations of 157 genetic variants that have been shown to be associated with plasma lipid levels in the Global Lipids Genetics Consortium that included 188 577 participants, mostly European ancestry, and genetic association with aortic stenosis as the main outcome from a total of 432 173 participants in the UK Biobank. Secondary negative control outcomes included aortic regurgitation and mitral regurgitation. The odds ratio for developing aortic stenosis per unit increase in lipid parameter was 1.52 [95% confidence interval (CI) 1.22-1.90; per 0.98 mmol/L] for low density lipoprotein (LDL)-cholesterol, 1.03 (95% CI 0.80-1.31; per 0.41 mmol/L) for high density lipoprotein (HDL)-cholesterol, and 1.38 (95% CI 0.92-2.07; per 1 mmol/L) for triglycerides. There was no evidence of a causal association between any of the lipid parameters and aortic or mitral regurgitation. CONCLUSION: Lifelong exposure to high LDL-cholesterol increases the risk of symptomatic aortic stenosis, suggesting that LDL-lowering treatment may be effective in its prevention.
引用
- Nazarzadeh M, Pinho-Gomes AC, Bidel Z, et al. Plasma lipids and risk of aortic valve stenosis: a Mendelian randomization study. Eur Heart J. 2020. PMID: 32076698. doi:10.1093/eurheartj/ehaa070
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。